The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Imagine the board meeting goes something like this...
Right team, how can we get great value for what we have? As you all know, there are many ways this can pan out. How about an option being we sell the diagnostic division, thus raising the SP and company value, as you all are aware that AVA6k will be the core to our success and BP will not allow us to hold it for long. We could also look for potential partners and then license it out once we have jumped over the final hurdles.
Imagine if we had a partner who has dealt with FDA several times. This will speed up fast track for AVA6k.
Let's put it this way, we can't keep the cat in the bag for too long.
I bet whoever is reading this can see the value and will go crazy to be some more.
Prtnear
Imagine if there has always been a company or two that had close eyes on Avacta
Imagine if they were interested before
How interested are they now
Remember this, a lot happens behind closed doors and I'm confident they will be privy to more than we know.
Deals/buyout
What could it be!
Still time to fill your boots
Presentation end of the month, be there.
Not long now.
The markets are tough and dry
The economic status of our society is forever declining.
If I can give myself an advise then that would be.... I should double my share holdings.
These prices will be a thing of the past.
Look at Nvidia, imagine being told of it whilst it was below $2 dollars.
We are sat exactly there, below £2... the world is your oyster.
Nothing comes without risk
I'm certain we have gone past that hurdle.
Selling at anything below £50 is abysmal.
I hope YOU do the right thing.
Good luck
FOMO is kicking in
I have bought and ready for the news.
News likely to land next week. Last week of August, as its promised for August, August it will be.
It should double at minimum is my thinking. But we will see, not long now.
Rise
Rise
Rise.
Same owner of Mobica?